No results for ‘’
Caplin Point Laboratories Ltd
₹2503.50
(6.11%)
Wed, 24 Jun 2026, 07:22 pm
Health Technology
Pharmaceuticals: Major
24.5KCaplin Point Laboratories Enterprise Value (EV)
| Particulars | 2006 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 9.29 | 15.70 | 6.01 | 6.32 | 5.37 | 4.87 | 5.08 | 12.94 | 25.06 | 30.68 | 30.06 | 17.32 | 10.01 | 12.73 | 17.32 | 12.13 | 21.99 | 28.51 |
| Price to book ratio | 0.96 | 0.50 | 0.56 | 0.83 | 1.16 | 1.16 | 1.65 | 5.42 | 11.92 | 13.05 | 11.91 | 4.81 | 2.25 | 2.58 | 3.47 | 2.41 | 4.32 | 5.48 |
| Price to sales ratio | 0.36 | 0.25 | 0.23 | 0.36 | 0.43 | 0.37 | 0.58 | 1.98 | 4.95 | 7.52 | 8.28 | 4.83 | 2.55 | 2.94 | 4.11 | 3.14 | 5.99 | 7.96 |
| Price to cash flow ratio | 6.67 | 15.26 | 1.07 | 32.35 | 2.34 | 1.33 | 2.11 | 5.85 | 34.26 | 40.03 | 60.64 | 36.09 | 44.24 | 11.10 | 14.60 | 15.35 | 27.82 | 31.62 |
| Enterprise value | 16.64Cr | 13.23Cr | 5.02Cr | 16.84Cr | 22.02Cr | 14.12Cr | 58.97Cr | 311Cr | 1462Cr | 2838Cr | 4269Cr | 2836Cr | 1916Cr | 2650Cr | 4706Cr | 3945Cr | 9295Cr | 14502Cr |
| Enterprise value to EBITDA ratio | 5.30 | 6.59 | 1.60 | 6.93 | 3.57 | 1.12 | 2.87 | 8.86 | 18.31 | 24.91 | 23.57 | 13.12 | 7.90 | 8.26 | 11.96 | 9.09 | 17.19 | 22.62 |
| Debt to equity ratio | 0.49 | 0.51 | 0.36 | 0.41 | 0.33 | 0.21 | 0.11 | 0.05 | 0.02 | 0 | 0 | 0 | 0.04 | 0.02 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 0 | 9.78 | 13.52 | 23.05 | 25.57 | 36.46 | 49.29 | 64.23 | 54.19 | 49.25 | 35.43 | 27.20 | 22.71 | 22.46 | 22.37 | 21.79 | 20.76 |
Caplin Point Laboratories Ltd Enterprise Value
The Caplin Point Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Caplin Point Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Caplin Point Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Caplin Point Laboratories Ltd (NSE: CAPLIPOINT, BSE: 524742) is currently trading at ₹2503.50, with a market capitalization of ₹17934.58Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Caplin Point Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Caplin Point Laboratories Ltd Enterprise Value Current Value
The current Caplin Point Laboratories Ltd Enterprise Value stands at 14502Cr.
The latest Caplin Point Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Caplin Point Laboratories Ltd Enterprise Value Historical Trend
The Caplin Point Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 14502Cr
- 2023: 9295Cr
- 2022: 3945Cr
- 2021: 4706Cr
- 2020: 2650Cr
The recent rise in Caplin Point Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Caplin Point Laboratories Ltd Enterprise Value Indicates for Investors
The Caplin Point Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd Enterprise Value Analysis Summary
The Caplin Point Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Caplin Point Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Caplin Point Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.